Gilead Sciences (GILD) Fails to deliver data

Key failure to deliver metrics for Gilead Sciences:

• Last SEC data release: 2024-12-13
• Last 15 days FTD volume: €2.2 M
• Last 3 months FTD volume: €47.11 M
• Last year FTD volume: €47.11 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Gilead Sciences (GILD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Gilead Sciences (GILD) - since 2013

Gilead Sciences (GILD) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Amgen AMGN	€32.27 M	€0.25 B	🇺🇸 USA
Vertex Pharmaceuticals VRTX	€19.65 M	€44.75 M	🇺🇸 USA
AbbVie ABBV	€87.11 M	€0.18 B	🇺🇸 USA
Illumina ILMN	€15.76 M	€54.99 M	🇺🇸 USA
Biogen BIIB	€24.89 M	€68.31 M	🇺🇸 USA
Pfizer PFE	€46.85 M	€0.35 B	🇺🇸 USA
Johnson & Johnson JNJ	€71.45 M	€0.33 B	🇺🇸 USA
Eli Lilly LLY	€76.19 M	€0.17 B	🇺🇸 USA
Merck MRK	€26.45 M	€97.06 M	🇺🇸 USA